Federal regulators are asking Novavax to complete an additional clinical trial on its Covid-19 vaccine after previously ...

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Novavax said on Wednesday the U.S. Food and Drug Administration had asked the company to produce more data on its COVID-19 ...

Novavax on Wednesday said the U.S. Food and Drug Administration has asked the company to commit to produce more data on its ...

Novavax shares declined after a Wall Street Journal report that federal regulators are asking the company to complete an additional randomized clinical trial on its Covid-19 vaccine, according to ...

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...

According to a statement that was released by Novavax on Wednesday, it appears that the Food and Drug Administration (FDA) of the United States of America will shortly give the COVID-19 vaccine its ...

Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full ...

Shares of Novavax Inc. NVAX slid 5.35% to $7.07 Thursday, on what proved to be an all-around favorable trading session for ...

The FDA is asking Novavax for a non-mandatory postmarketing commitment to produce additional clinical data for its ...